Pfizer is closing two of its three sites in Britain following a review of its global supply network. The facilities employ 370 people. This follows news of the company dropping its anti-cholesterol drug, bococizumab, from trials as well as the EPA fining a Pfizer plant in Barceloneta, Puerto Rico.
According to company spokespeople, Pfizer's Hospira UK (Aseptic Services) Compounding site in North London, will close in the middle of next year while a packaging and distribution site in Havant, southern England, will close by the end of 2020.
"It is important to note that these proposals are in no way related to the result of the Brexit decision," a company spokesperson said. Instead, the company says it had been reviewing these facilities since 2010.
Read the Reuters report